[Molecular pathogenesis of ocular vascular disease--anti-angiogenesis as a therapeutic concept].

Joussen, A M

[Molecular pathogenesis of ocular vascular disease--anti-angiogenesis as a therapeutic concept]. [electronic resource] - Deutsche medizinische Wochenschrift (1946) Jun 2007 - 1268-72 p. digital

Publication Type: Journal Article; Review

1439-4413

10.1055/s-2007-982025 doi


Angiogenesis Inhibitors--therapeutic use
Antibodies, Monoclonal--therapeutic use
Antibodies, Monoclonal, Humanized
Aptamers, Nucleotide--therapeutic use
Bevacizumab
Diabetic Angiopathies--drug therapy
Diabetic Retinopathy--drug therapy
Humans
Infant, Newborn
Macular Degeneration--drug therapy
Neovascularization, Pathologic--drug therapy
Ranibizumab
Retinal Diseases--drug therapy
Retinopathy of Prematurity--drug therapy
Vascular Diseases--drug therapy